PAR
Click for more information
12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-455

  1. oxxa23
    5,933 Posts.
    lightbulb Created with Sketch. 1138
    clock Created with Sketch.
    15/01/20
    14:10
    Post #: 42393079
    Cap raise would show in the cashflow statement, not in the profit and loss. It doesn't qualify as income in accounting standards.
    PAR Price at posting: $3.64 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
OBM Ora Banda sees FY26 gold output jumping to 150Koz/pa following key approval for Sand King
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢ 		Change
0.035(12.7%) 		Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.